FASSIHI REZA 4
4 · SCOLR Pharma, Inc. · Filed Aug 29, 2006
Insider Transaction Report
Form 4
FASSIHI REZA
Director
Transactions
- Sale
Common Stock
2006-08-25$4.89/sh−2,000$9,780→ 4,067 total - Sale
Common Stock
2006-08-25$4.73/sh−500$2,365→ 33,567 total - Sale
Common Stock
2006-08-25$4.88/sh−2,600$12,688→ 6,067 total - Sale
Common Stock
2006-08-25$4.80/sh−5,100$24,480→ 25,367 total - Sale
Common Stock
2006-08-25$4.82/sh−100$482→ 24,267 total - Sale
Common Stock
2006-08-24$4.80/sh−2,700$12,960→ 35,367 total - Sale
Common Stock
2006-08-28$4.97/sh−4,000$19,880→ 67 total - Sale
Common Stock
2006-08-24$4.82/sh−500$2,410→ 34,067 total - Sale
Common Stock
2006-08-25$4.83/sh−600$2,898→ 23,667 total - Sale
Common Stock
2006-08-24$4.81/sh−800$3,848→ 34,567 total - Sale
Common Stock
2006-08-25$4.81/sh−1,000$4,810→ 24,367 total - Sale
Common Stock
2006-08-25$4.79/sh−3,100$14,849→ 30,467 total - Sale
Common Stock
2006-08-25$4.87/sh−11,400$55,518→ 8,667 total